Sydney University is doing a study on Fear of Recurrence ....... check it out
The things that pop into my FB stream ..... Yesterday it was notification that Sydney Uni is doing a 'Fear of Recurrence' Study & is asking anyone with breast or Ovarian cancers to take part ...... and to 'pick the right answer' - Yes or No - as to whether the answer is correct or not - the word/question/answer is about us reading more into (or overthinking) words or statements or symptoms. https://sydney.au1.qualtrics.com/CP/File.php?F=F_0lJ5WV6FXMxCJls I did it last night and if getting the answers wrong means that I have a fear of recurrence - I reckon I'll be in the top 10%!! :( I must have 'passed' - as I get another set of questions next week!! COGNITIVE BIAS MODIFICATION (CBM) FOR FEAR OF CANCER RECURRENCE/PROGRESSION You are invited to take part in a research study looking at a novel intervention for fear of cancer recurrence or progression (FCR), known as Cognitive Bias Modification (CBM). FCR is natural and common amongst cancer survivors, and leads people living beyond cancer to interpret many situations in light of their experience (a potential threat of recurrence or progression). CBM is an intervention that is administered online and trains people not to interpret ambiguous situations in a threatening way. By doing so, people reduce their anxiety. CBM has been shown to be helpful in a range of populations including in people with anxiety and depression. However there is only one pilot study in people living beyond breast cancer. That study achieved promising results, and we aim to test CBM in a larger trial to see if CBM does reliably reduce FCR, and if the results extend to women with ovarian cancer. https://sydney.au1.qualtrics.com/jfe/form/SV_8HRDp6WSgjjXXpA?fbclid=IwAR2fB8uR9MnChFi0ZcaClfxA5w3HI_B0jN6ZVvcOCzVo6MhXIz6nVJ77yc8211Views0likes12Comments
New study aimed at relieving hot flushes
New study aimed at relieving hot flushes and night sweats experienced by women after breast cancer Researchers in the Monash Women’s Health Research Program are conducting a study to evaluate a potential new treatment aimed at relieving hot flushes and night sweats in women diagnosed with breast cancer who are taking hormone blocking therapy (either tamoxifen or an aromatase inhibitor). While clinical trials have found hormone blocking therapy can significantly reduce the risk of breast cancer coming back (recurring), many women experience menopausal-like symptoms when taking hormone-blocking therapy. While these side effects are mild for many women or lessen over time, some women experience significant symptoms which can be difficult to cope with. The study will determine whether QUE 122 (a small molecule which was found to lessen hot flushes and night sweats in an earlier study) is effective in reducing night sweats and hot flushes in women affected by breast cancer being treated with hormone blocking therapy. You may be eligible to participate if you are: · Aged 18 to 70 years Have been taking tamoxifen or an aromatase inhibitor (i.e. anastrozole (Arimidex), letrozole (Femara) or exemestane (Aromasin) for at least 1 month · Are experiencing 7 or more hot flushes/night sweats each day. This study is taking place at sites in Melbourne, Sydney, Adelaide and Perth. If you are interested in participating or would like further information, please email womens.health@monash.edu call Corallee on +61 3 9903 0836. More information about the study is also available on the Women’s Health Research Program’s website. For information about hormone blocking therapy, including how the drugs work, why they are beneficial and tips / strategies to help manage side effects, download BCNA’s Hormone therapy and breast cancer booklet on www.bcna.org.au1KViews1like31Comments
Research study - Share your views about how cancer treatment and care can be improved
If you've been diagnosed with breast or any other cancer and want to have a say about how cancer care can be improved, you are invited to share your views about how cancer treatment can be improved via an online survey being conducted by All.Can. All.Can is an international initiative which has been set up to identify common issues people affected by cancer experience around the world and identify how cancer care can be improved. This survey is part of a global research project to better understand people's experiences of cancer treatment, what barriers exist which are preventing people from receiving the best cancer treatment and care and what improvements can be made. The survey takes about 10-40 minutes to complete. You can find out more information about the research project and participate in the online survey here: http://www.myonlinesurvey.co.uk/allcan_ENAU/. Thanks very much for taking the time to consider this opportunity!361Views3likes13Comments